BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 2148189)

  • 1. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
    Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney.
    Brier ME; Brier RA; Luft FC; Aronoff GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):868-73. PubMed ID: 2961879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H; Pedersen EB
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of atrial natriuretic peptide infusion in young and adult rats.
    Chevalier RL; Gomez RA; Carey RM; Peach MJ; Linden JM
    Pediatr Res; 1988 Sep; 24(3):333-7. PubMed ID: 2850523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
    Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
    Takagi H; Takahara A; Tomura Y; Yamagata T; Hisa H; Satoh S
    J Pharmacol Exp Ther; 1993 Oct; 267(1):456-61. PubMed ID: 8229776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide and the kidney.
    Ballermann BJ; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):7-12. PubMed ID: 3037892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and hemodynamic effects of synthetic atrial natriuretic peptide in dogs with chronic renal failure.
    Tsuchiya K; Sanaka T; Ando A
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):151-7. PubMed ID: 2525634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
    Nielsen CB; Pedersen EB
    Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of atrial natriuretic peptide and amiloride on renal hemodynamics through renal kallikrein and kinins in anesthetized rabbits.
    Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S39-42. PubMed ID: 2473347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of atrial natriuretic peptide and amiloride on renal haemodynamics and the renal kallikrein-kinin system.
    Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
    J Hypertens; 1988 Apr; 6(4):321-7. PubMed ID: 2967862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atrial natriuretic peptide on the release of rat renal kallikrein.
    Klein HG; Schöneck V; Obika LF; Odigie P; Angchanpen P; Marin-Grez M
    Miner Electrolyte Metab; 1989; 15(3):130-6. PubMed ID: 2524641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.